FilingReader Intelligence
Kwality Pharma gets Mexico cancer drug registration
August 18, 2025 at 06:19 AM UTC•By FilingReader AI
Kwality Pharmaceuticals Limited confirmed registration of Bleomycin 15 IU per vial in Mexico, enabling sale and distribution of the anti-cancer medicine for Hodgkin's lymphoma and testicular cancer.
The company projects initial business potential of $1m in the first year, with supplies starting before Q2FY26.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:KPL•Bombay Stock Exchange
News Alerts
Get instant email alerts when Kwality Pharmaceuticals publishes news
Free account required • Unsubscribe anytime